Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: Echocardiographic and tissue Doppler imaging assessment

Journal of Clinical Gastroenterology

Volumn 40, Issue 10, 2006, Pages 949-955

  Goland, Sorel ^a   Shimoni, Sara ^a   Zornitzki, Taiba ^a   Knobler, Hilla ^a   Azoulai, Orly ^a   Lutaty, Gaby ^a   Melzer, Ehud ^a   Orr, Ayella ^a   Caspi, Avraham ^a   Malnick, Stephen ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

LV diastolic dysfunction; Metabolic syndrome; Nonalcoholic fatty liver disease

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; DOPPLER FLOWMETRY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MORBID OBESITY; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SYSTOLE; TRIACYLGLYCEROL BLOOD LEVEL; VELOCITY;

ADULT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FATTY LIVER; FEMALE; HEART RATE; HEART SEPTUM; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ISRAEL; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 33750630075     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225668.53673.e6     Document Type: Article

References (43)

1. Malnick SDH, Beergabel M, Knobler H. Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. QJM. 2003;96:699-709.
2. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gatroenterology. 2002;122:1649-1657.
3. Knobler H, Schattner A, Zhornicki T, et al. Fatty liver - an additional and treatable feature of the insulin resistance syndrome. QJM. 1999;92:73-79.
4. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450-455.
5. Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndromeXin severe obesity. J Clin Endocrinol Metab. 1999;84:1513-1517.
6. Comert B, Mas MR, Erdem H, et al. Insulin resistance in non-alcoholic steatohepatitis. Dig Liver Dis. 2001;33:353-358.
7. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults: findings from the third national Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
8. Alexander CM, Landsman PB, Teutsch SM, et al. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-1214.
9. Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol. 2004;43:1399-1404.
10. Chinali M, Devereux RB, Howard BV, et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol. 2004;93:40-44.
11. Sasson Z, Rasooly Y, Bhesania T, et al. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88(Pt 1):1431-1436.
12. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25:879-884.
13. Petersen KF, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664-671.
14. Hintz KK, Ren J. Prediabetic insulin resistance is not permissive to the development of cardiac resistance to insulin-like growth factor I in ventricular myocytes. Diabetes Res Clin Pract. 2002;55:89-98.
15. Dutta K, Podolin DA, Davidson MB, et al. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes. 2001;50:1186-1192.
16. Garcia MJ, Rodriguez L, Ares M, et al. Myocardial wall velocity assessment by pulsed Doppler tissue imaging: characteristic findings in normal subjects. Am Heart J. 1996;132:648-656.
17. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler- catheterization study. Circulation. 2000;102:1788-1794.
18. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108-1112.
19. Quinn SF, Gosnik BB. Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol. 1985;145:753-755.
20. Celle G, Savarino V, Picciotto A, et al. Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. Dig Dis Sci. 1988;33:467-471.
21. Nomura H, Kashiwagi S, Hayashi J, et al. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med. 1988;27:142-149.
22. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary on the National Cholesterol Education Programme (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2496.
23. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
24. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
25. Tei C, Nishimura RA, Seward JB, et al. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169-178.
26. Goland S, Shimoni S, Livschitz S, et al. Dipyridamole-induced abnormal Tl-201 lung uptake in patients with normal myocardial perfusion: a marker of increased left ventricular filling pressures. J Nucl Cardiol. 2004;11:305-311.
27. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321.
28. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649-1657.
29. Jick SS, Stender M, Myers MW. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care. 1999;22:2067-2071.
30. Comert B, Mas MR, Erdem H, et al. Insulin resistance in nonalcoholic steatohepatitis. Dig Liver Dis. 2001;33:353-358.
31. Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res. 2003;11:518-524.
32. Davis CL, Kapuku G, Snieder H, et al. Insulin resistance syndrome and left ventricular mass in healthy young people. Am J Med Sci. 2002;324:72-75.
33. Paternostro G, Pagano D, Gnecchi-Ruscone T, et al. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res. 1999;42:246-253.
34. Hirayama H, Sugano M, Abe N, et al. Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients. Int J Cardiol. 2001;77:75-79.
35. Galvan AQ, Galetta F, Natali A, et al. Insulin resistance and hyperinsulinemia: no independent relation to left ventricular mass in humans. Circulation. 2000;102:2233-2238.
36. Vaccaro O, Cardoni O, Cuomo V, et al. Gubbio Study Research Group. Relationship between plasma insulin and left ventricular mass in normotensive participants of the Gubbio Study. Clin Endocrinol (Oxf). 2003;58:316-322.
37. Miyazato J, Horio T, Takishita S, et al. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension. Hypertens Res. 2002;25:403-409.
38. Galderisi M, Tagliamonte MR, D'Errico A, et al. Independent association of plasma leptin levels and left ventricular isovolumic relaxation in uncomplicated hypertension. Am J Hypertens. 2001;14:1019-1024.
39. Nagueh SF, McFalls J, Meyer D, et al. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 2003;108:395-398.
40. 2). Am J Cardiol. 2004;94:1087-1090.
41. Villanova N, Moscatiello S, Bugianesi E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology. 2005;42:473-480.
42. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
43. Williams B, Poulter NR, Brown MJ, et al. BHS guidelines working party, for the British Hypertension Society. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004;328:625-629.